-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Nuo Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Nuo Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$577K, a 26.9% increase year-over-year.
- Nuo Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$2.48M, a 28.7% increase year-over-year.
- Nuo Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$3.17M, a 4.59% increase from 2022.
- Nuo Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$3.32M, a 3562% decline from 2021.
- Nuo Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$90.7K, a 76% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)